Polygenic embryo screening (PES) examines embryos for their genetic likelihood of developing complex conditions and traits. The commercialization of PES places Reproductive Endocrinologists & Infertility specialists (REIs) as the primary decision makers on its use, despite professional guidelines cautioning that PES is not ready for clinical use.